Insider Trading Alert - MDSO, INT, SYK, ITT And DFS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 7, 2013, 132 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.62 to $810,125,000.00.

Highlighted Stocks Traded by Insiders:

Medidata Solutions (MDSO) - FREE Research Report

Sherif Tarek who is Chairman & CEO at Medidata Solutions sold 30,000 shares at $109.97 on Nov. 7, 2013. Following this transaction, the Chairman & CEO owned 499,275 shares meaning that the stake was reduced by 5.67% with the 30,000 share transaction.

The shares most recently traded at $109.41, down $0.56, or 0.51% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 5,871
  • 12-Week # shares sold: 5,871
  • 24-Week # shares sold: 73,093

The average volume for Medidata Solutions has been 236,000 shares per day over the past 30 days. Medidata Solutions has a market cap of $2.8 billion and is part of the technology sector and computer software & services industry. Shares are up 171.16% year to date as of the close of trading on Thursday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company has a P/E ratio of 123.5. Currently there are 4 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Insider Trading Alert - MDSO, BDN And COBZ Traded By Insiders

Stock To Watch: Medidata Solutions (MDSO) In Perilous Reversal

Medidata Solutions (MDSO) Is Strong On High Volume Today

Insider Trading Alert - MDSO, ATEN And MDRX Traded By Insiders

Insider Trading Alert - MDSO, KAI And VVUS Traded By Insiders